← U S PHYSICAL THERAPY INC /NV
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $356.5m |
$414.1m
+16.13%
|
$453.9m
+9.63%
|
$482.0m
+6.18%
|
$423.0m
-12.24%
|
$495.0m
+17.04%
|
$553.1m
+11.74%
|
$604.8m
+9.34%
|
$671.3m
+11.00%
|
$781.0m
+16.33%
|
$812.2m
+4.00%
|
|
| Cost of Revenue | $274.5m |
$323.4m
+17.81%
|
$352.2m
+8.91%
|
$369.5m
+4.90%
|
$328.5m
-11.09%
|
$377.8m
+15.01%
|
$441.1m
+16.75%
|
$483.3m
+9.56%
|
$547.4m
+13.27%
|
$631.3m
+15.32%
|
$660.5m
+4.63%
|
|
| Gross Profit | $82.0m |
$90.6m
+10.49%
|
$101.7m
+12.19%
|
$112.5m
+10.63%
|
$94.5m
-16.03%
|
$117.2m
+24.07%
|
$112.0m
-4.40%
|
$121.5m
+8.47%
|
$123.9m
+1.99%
|
$149.7m
+20.80%
|
$151.7m
+1.34%
|
|
| Selling, General and Administrative Expense | $32.5m | $35.9m | $41.3m | $45.0m | $42.0m | $46.5m | $46.1m | $52.0m | $58.3m | $69.3m | — | |
| Labor and Related Expense | $198.5m | $237.1m | $259.2m | $274.2m | $235.6m | $278.5m | $319.2m | $353.4m | $399.4m | $461.9m | — | |
| Amortization of Intangible Assets | $2.4m | $2.7m | $2.8m | $3.0m | $3.4m | $3.7m | $6.5m | $7.3m | $9.5m | $11.3m | — | |
| Operating Income (Loss) | $49.5m |
$54.7m
+10.49%
|
$60.3m
+10.21%
|
$67.4m
+11.79%
|
$52.4m
-22.26%
|
$70.6m
+34.79%
|
$56.8m
-19.60%
|
$52.1m
-8.34%
|
$63.2m
+21.42%
|
$86.7m
+37.12%
|
$78.9m
-8.99%
|
|
| Interest Expense | $11.5m | $21.1m | $2.0m | $2.1m | — | — | — | — | — | — | $10.8m | |
| Other Nonoperating Income (Expense) | — | — | — | — | — | — | — | $390k | $357k | $458k | — | |
| Income (Loss) from Equity Method Investments | — | — | — | — | — | $112k | $1.2m | $955k | $1.0m | $1.5m | — | |
| Interest and Other Income | $93k | $88k | $93k | $46k | $142k | $199k | $859k | — | — | — | — | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $38.1m | $33.8m | $60.2m | $70.9m | $65.5m | $73.2m | $55.6m | $49.4m | $60.2m | $77.8m | $67.4m | |
| Current Income Tax Expense (Benefit) | $8.9m | $10.9m | $6.6m | $9.0m | $13.3m | $9.6m | ($252k) | $7.5m | $9.7m | $9.2m | $17.6m | |
| Income Tax Expense (Benefit) | $11.9m | $6.0m | $11.4m | $13.6m | $13.0m | $15.3m | $12.2m | $12.2m | $14.6m | $19.8m | $17.6m | |
| Net Income (Loss) Attributable to Parent | $20.6m |
$22.3m
+8.30%
|
$34.9m
+56.69%
|
$40.0m
+14.81%
|
$35.2m
-12.10%
|
$40.8m
+16.02%
|
$32.2m
-21.24%
|
$28.2m
-12.19%
|
$31.4m
+11.28%
|
$39.6m
+25.96%
|
$2.7m
-93.28%
|
|
| Net Income (Loss) Available to Common Stockholders, Basic | $26.3m |
$27.5m
+4.61%
|
$34.9m
+26.90%
|
$40.0m
+14.81%
|
$35.2m
-12.10%
|
$40.8m
+16.02%
|
$32.2m
-21.24%
|
$28.2m
-12.19%
|
$31.4m
+11.28%
|
$39.6m
+25.96%
|
$2.7m
-93.28%
|
|
| Net Income (Loss) Attributable to Noncontrolling Interest | $5.7m | $5.5m | $14.0m | $17.2m | $17.3m | $17.1m | $11.2m | $9.0m | $14.2m | $18.4m | $2.7m | |
| Noncontrolling Interest in Net Income (Loss) Other Noncontrolling Interests, Redeemable | $0 | $119k | — | — | — | — | — | — | — | — | — | |
| Earnings Per Share, Basic | $0.68 | $0.80 | $0.92 | $1.14 | $0.32 | $2.41 | $2.25 | $1.28 | $1.84 | $1.42 | $0.17 | |
| Earnings Per Share, Diluted | $1.64 | $1.76 | $1.31 | $2.45 | $2.48 | $2.41 | $2.25 | $1.28 | $1.84 | $1.42 | $0.17 | |
| Common Stock, Dividends, Per Share, Declared | $0.68 | $0.00 | $0.00 | $0.00 | $0.00 | $1.46 | $1.64 | $1.72 | $1.76 | $1.80 | — | |
| Weighted Average Number of Shares Outstanding, Basic | 12.5m | — | — | — | — | 12.9m | 13.0m | 14.2m | 15.1m | 15.2m | 15.2m | |
| Weighted Average Number of Shares Outstanding, Diluted | 12.5m | — | — | — | — | 12.9m | 13.0m | 14.2m | 15.1m | 15.2m | 15.2m | |
| Additional Financial Items | ||||||||||||
| Costs and Expenses | $274.5m | $323.4m | $352.2m | $369.5m | $328.5m | $377.8m | $441.1m | $483.3m | $547.4m | $631.3m | — | |
| Goodwill, Impairment Loss | — | — | — | — | $1.9m | $0 | $9.1m | $15.8m | $0 | $0 | $0 |